How loss of key protein promotes aggressive form of leukemia

How loss of key protein promotes aggressive form of leukemia
New research illuminates in fine detail one of the genetic paths that leads to a particularly aggressive form of leukemia. A team discovered a new tumor-suppressing function of p53, distinct, for instance, from apoptosis, and somewhat related to senescence. They showed that it has the ability to reinforce cell-fate and differentiation programs. In AML, p53 loss leads to cancer by disabling this …
Read more on Science Daily

Medicare considers Dendreon cancer treatment
NEW YORK (MarketWatch) — Dendreon Corp. shares fell in premarket Thursday after the drug maker said late Wednesday the Medicare & Medicaid Services is reviewing its prostate cancer vaccine Provenge for nationwide coverage. The agency expects to make a decision by March 30, 2011, if the treatment is necessary for Medicare, a federal programs that covers about 45 million senior and disabled …
Read more on Market Watch